• 19/07/2021

    Publication: Results of the acceptability & feasibility study of the BPaL regimen

    A study, conducted by KNCV Tuberculosis Foundation and TB Alliance, shows that the adoption of BPal…

    Lees meer
  • 15/07/2021

    New Trial Results Show Effectiveness of BPaL Regimen for Highly Drug-Resistant TB Can Be Maintained with Reduced Dosing of Linezolid

    TB Alliance’s ZeNix trial in South Africa and Eastern Europe sought to optimize the 6-month treatment regimen with reduced exposure…

    Lees meer
  • 15/07/2021

    Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development

    15 July 2021, The Hague. To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions…

    Lees meer
  • 18/06/2021

    Welcome Dr. Harsh Vardhan, India’s Minister of Health, as new Chair of Stop TB Partnership

    KNCV Tuberculosis Foundation welcomes His Excellency Dr. Harsh Vardhan as the new chair of the Stop TB Partnership Board. We are confident that…

    Lees meer
  • 21/05/2021

    Appointments Board of Trustees

    May 11, 2021 the KNCV Members Association appointed Tjipke Bergsma and René Stumpel to the Board of Trustees and re-appointed…

    Lees meer
  • 18/05/2021

    The first TB patient in Nigeria to be treated with the BPaL regimen

    Ruth Iliya, who was first diagnosed in January 2021 is the first TB patient in Nigeria to be treated with…

    Lees meer
  • 18/05/2021

    New hope for drug resistant tuberculosis (TB) patients in Nigeria

    Nigeria is the first country in West Africa to provide people with tuberculosis (TB) access to the groundbreaking new BPaL…

    Lees meer
  • 12/05/2021

    Directory of TB vaccine clinical trial sites

    There are approximately 14 vaccine candidates for tuberculosis (TB). Over the upcoming 10 years these need to be tested in…

    Lees meer
  • 07/05/2021

    KNCV Nigeria won Cepheids Make it Happen Award

    KNCV Nigeria won the Cepheid Make it Happen Award for their Wellness on Wheels (WoW) project. This price…

    Lees meer
  • 24/03/2021

    Easy and child-friendly tuberculosis diagnosis in rural Ethiopia

    Mesay Gebre and her family of five live in Umiya, a mostly rural region in Ethiopia. They depend completely on…

    Lees meer
  • 18/03/2021

    Join us at the SOS Stoolbox Symposium!

    On 25 March 2021, KNCV Tuberculosis Foundation will hold a virtual symposium to celebrate the launch of the SOS Stoolbox.

    Lees meer
  • 16/03/2021

    KNCV Executive Director Mustapha Gidado: “Positive COVID test made me anxious”

    COVID19 is affecting us all, personally and professionally. Doctors, epidemiologists and infectious disease experts have also become infected and fallen…

    Lees meer
  • 08/03/2021

    TB diagnosed in time in Ethiopian family

    Selamawit, a mother of two, lives with her husband in Mole Kebele, Ethiopia. Her youngest daughter, who is now…

    Lees meer
  • 08/03/2021

    Iddirs in Ethiopia help diagnose tuberculosis in children

    In Ethiopia, female self-help associations, called “Iddirs”, help diagnose tuberculosis (TB) in children. These women receive training in which they…

    Lees meer
  • 01/02/2021

    Tell the Netherlands to invest in healthcare worldwide

    It’s become clear to everyone now; diseases know no borders. COVID-19 has shaken the whole world up about the importance…

    Lees meer

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.